BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12022349)

  • 1. The rate and pattern of organ damage in late onset systemic lupus erythematosus.
    Maddison P; Farewell V; Isenberg D; Aranow C; Bae SC; Barr S; Buyon J; Fortin P; Ginzler E; Gladman D; Hanly J; Manzi S; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G;
    J Rheumatol; 2002 May; 29(5):913-7. PubMed ID: 12022349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.
    Lalani S; Pope J; de Leon F; Peschken C;
    J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus.
    Gutiérrez-Suárez R; Ruperto N; Gastaldi R; Pistorio A; Felici E; Burgos-Vargas R; Martini A; Ravelli A
    Arthritis Rheum; 2006 Sep; 54(9):2989-96. PubMed ID: 16947634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
    Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.
    Ravelli A; Duarte-Salazar C; Buratti S; Reiff A; Bernstein B; Maldonado-Velazquez MR; Beristain-Manterola R; Maeno N; Takei S; Gerloni V; Spencer CH; Pratsidou-Gertsi P; Ruperto N; Pistorio A; Martini A
    Arthritis Rheum; 2003 Aug; 49(4):501-7. PubMed ID: 12910556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serologic factors associated with lupus pleuritis.
    Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
    J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
    Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD;
    Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
    Bertoli AM; Alarcón GS; Calvo-Alén J; Fernández M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2006 May; 54(5):1580-7. PubMed ID: 16645994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
    Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
    Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accrual of organ damage over time in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
    J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.